Apolipoprotein E genotyping in patients with neurodegenerative diseases

被引:5
作者
Ballering, LAP
SteffensNakken, HM
Esselink, RAJ
DeVos, RAI
Steur, RNHJ
Vermes, I
机构
[1] MED SPECTRUM TWENTE,DEPT CLIN CHEM,HOSP GRP,NL-7500 KA ENSCHEDE,NETHERLANDS
[2] MED SPECTRUM TWENTE,DEPT NEUROL,HOSP GRP,NL-7500 KA ENSCHEDE,NETHERLANDS
[3] REG LAB PATHOL,ENSCHEDE,NETHERLANDS
关键词
apolipoprotein E; genotyping; Parkinson's disease; Alzheimer's disease; formalin fixed paraffin-embedded brain tissue; semi-nested PCR;
D O I
10.1016/S0009-9120(97)00003-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: There is a growing demand to perform apolipoprotein E (Apo-E) genotyping on neuropathologic archive material. Due to the extremely long fixation time, this material is unsuitable for routinely used Apo-E genotyping methods. We present an investigation into the applicability of a new method. Design and Methods: An Apo-E genotyping method was tested for use on formalin-fixed paraffin-embedded brain tissue, using semi-nested PCR followed by hybridization with biotin-labeled allele-specific oligonucleotides, and chemiluminescent detection. The method was applied to 88 archive samples of different neurologic disorders. Results: With this technique 76% (67/88) of the samples could be genotyped. The crucial step is the semi-nested PCR. All the samples from which a PCR product could be obtained, the Apo-E gene could be genotyped without interpretation problems. Seventy-six percent of the samples that could not be genotyped, were fixed in unbuffered formalin. Conclusions: This technique offers a good Apo-E genotyping method applicable on neuropathological archive material in order to support in retrospect clinical studies.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 28 条
[1]  
*ACMG ASHG WORK GR, 1995, JAMA-J AM MED ASSOC, V274, P1627
[2]   THE APOLIPOPROTEIN-E ALLELES AS MAJOR SUSCEPTIBILITY FACTORS FOR CREUTZFELDT-JAKOB-DISEASE [J].
AMOUYEL, P ;
VIDAL, O ;
LAUNAY, JM ;
LAPLANCHE, JL .
LANCET, 1994, 344 (8933) :1315-1318
[3]   APOLIPOPROTEIN-E GENE IN PARKINSONS-DISEASE WITH OR WITHOUT DEMENTIA [J].
ARAI, H ;
MURAMATSU, T ;
HIGUCHI, S ;
SASAKI, H ;
TROJANOWSKI, JQ .
LANCET, 1994, 344 (8926) :889-889
[4]  
BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393
[5]  
BRENNINKMEIJER BJ, 1986, ARTERIOSCLEROSIS, V6, pA546
[6]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[7]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[8]  
EGENSPERGER R, 1995, ACTA NEUROPATHOL, V90, P257
[9]  
EGGERTSEN G, 1993, CLIN CHEM, V39, P2125
[10]   GENOTYPING AND SEQUENCE-ANALYSIS OF APOLIPOPROTEIN-E ISOFORMS [J].
EMI, M ;
WU, LL ;
ROBERTSON, MA ;
MYERS, RL ;
HEGELE, RA ;
WILLIAMS, RR ;
WHITE, R ;
LALOUEL, JM .
GENOMICS, 1988, 3 (04) :373-379